Peter Greenleaf Insider Trading $SYBX SYNLOGIC, INC.
Get free email notifications about insider trading for Peter Greenleaf.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Greenleaf. Peter Greenleaf is Senior VP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales and Marketing in MEDIMMUNE INC /DE ($MEDI) and Director in ANTARES PHARMA, INC. ($ATRS) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and Director in Mast Therapeutics, Inc. ($MSTX) and CEO in Sucampo Pharmaceuticals, Inc. ($SCMP) and Chief Executive Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and Director in Mirna Therapeutics, Inc. ($MIRN) and in Cerecor Inc. ($CERC) and Chief Executive Officer in Cerecor Inc. ($CERC) and Director in Cerecor Inc. ($CERC) and Chief Executive Officer in Aurinia Pharmaceuticals Inc. ($AUPH).
Peter Greenleaf in SYNLOGIC, INC.
Trading Symbol: SYBXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 06 2016
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Greenleaf in SYNLOGIC, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, AUPH, BDSI, CERC, EYEG, MEDI, SVRA, SCMP, SYBX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 06 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
Mar 14 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.36 | 8,000 | 34,880 | 8,000 | |
Mar 02 2016 | MIRN | Mirna Therapeutics ... | Greenleaf Peter | Director | Option Exercise | A | 4.55 | 12,000 | 54,600 | 12,000 |
Page: 1